BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10692733)

  • 1. A prospective audit of hospital-acquired deep vein thrombosis and pulmonary embolism.
    Wright G; Elliott K; Wilkie C; Cuschieri RJ; Bittiner B; Hughes KB
    Int J Clin Pract; 1999; 53(7):497-504. PubMed ID: 10692733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative management of epistaxis: are we putting patients at risk of developing venous thromboembolic complications?
    Karagama YG; Anari S; Lancaster JL; Karkanevatos A; Jones TM; Sherman IW
    Rhinology; 2005 Jun; 43(2):135-7. PubMed ID: 16008070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of deep venous thrombosis and pulmonary embolism in urogynecologic surgical patients.
    Solomon ER; Frick AC; Paraiso MF; Barber MD
    Am J Obstet Gynecol; 2010 Nov; 203(5):510.e1-4. PubMed ID: 20800214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboembolic complications after spinal surgery in trauma patients.
    Platzer P; Thalhammer G; Jaindl M; Obradovic A; Benesch T; Vecsei V; Gaebler C
    Acta Orthop; 2006 Oct; 77(5):755-60. PubMed ID: 17068706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of illness in venous thromboembolism in critical care: a multicenter observational study.
    Patel R; Cook DJ; Meade MO; Griffith LE; Mehta G; Rocker GM; Marshall JC; Hodder R; Martin CM; Heyland DK; Peters S; Muscedere J; Soth M; Campbell N; Guyatt GH; ;
    J Crit Care; 2005 Dec; 20(4):341-7. PubMed ID: 16310605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
    Leizorovicz A; Cohen AT; Turpie AG; Olsson CG; Vaitkus PT; Goldhaber SZ;
    Circulation; 2004 Aug; 110(7):874-9. PubMed ID: 15289368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thrombosis after long-haul flights.
    Schwarz T; Siegert G; Oettler W; Halbritter K; Beyer J; Frommhold R; Gehrisch S; Lenz F; Kuhlisch E; Schroeder HE; Schellong SM
    Arch Intern Med; 2003 Dec 8-22; 163(22):2759-64. PubMed ID: 14662630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and factors predicting pulmonary embolism and deep venous thrombosis following surgical treatment of ankle fractures.
    SooHoo NF; Eagan M; Krenek L; Zingmond DS
    Foot Ankle Surg; 2011 Dec; 17(4):259-62. PubMed ID: 22017898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.
    Anderson FA; Wheeler HB; Goldberg RJ; Hosmer DW; Patwardhan NA; Jovanovic B; Forcier A; Dalen JE
    Arch Intern Med; 1991 May; 151(5):933-8. PubMed ID: 2025141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital-acquired venous thromboembolism and prophylaxis in an integrated hospital delivery system.
    Dorfman M; Chan SB; Maslowski C
    J Clin Pharm Ther; 2006 Oct; 31(5):455-9. PubMed ID: 16958823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current assessment of thromboembolic disease and pregnancy.
    Armour R; Schwedler M; Kerstein MD
    Am Surg; 2001 Jul; 67(7):641-4. PubMed ID: 11450779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
    DeBernardo RL; Perkins RB; Littell RD; Krasner CN; Duska LR
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1006-11. PubMed ID: 15863537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting.
    Ennis RS
    J South Orthop Assoc; 2003; 12(1):10-7. PubMed ID: 12735619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
    Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
    Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study.
    Eriksson BI; Lassen MR;
    Arch Intern Med; 2003 Jun; 163(11):1337-42. PubMed ID: 12796070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of pulmonary embolism: is it declining?
    Bergqvist D
    Semin Vasc Surg; 2000 Sep; 13(3):167-70. PubMed ID: 11005459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical limitations of risk assessment models.
    Lassen MR; Borris LC; Backs S; Kaltoft-Sørensen M; Coff-Ganes H; Jeppesen E
    Blood Coagul Fibrinolysis; 1999 Aug; 10 Suppl 2():S45-51. PubMed ID: 10493230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Deep-vein thrombosis and pulmonary embolism due to air travel].
    Levi M; Rosendaal FR; Büller HR
    Ned Tijdschr Geneeskd; 2006 Nov; 150(45):2474-8. PubMed ID: 17137092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.